Other
AbbVie shares sink after $21 bn deal for Pharmacyclics
AbbVie shares sank Thursday after the US pharmaceutical firm announced it will buy leukemia drug maker Pharmacyclics in a $21 billion deal.
Mar 5, 2015
0
3
Page 7 - News tagged with acquisitions
HIV & AIDS
Study supports link between injectable hormonal contraceptive and HIV risk
Women using depot medroxyprogesterone acetate (DMPA), commonly known as Depo-Provera or the birth control shot, have a moderately increased risk of becoming infected with HIV, a large meta-analysis of 12 studies involving ...
Jan 9, 2015
0
9
Medications
Health care M&A leads global deal surge
In a big year for deal making, the health care industry is a standout. Large drugmakers are buying and selling businesses to control costs and deploy surplus cash. A rising stock market, tax strategies and low interest rates ...
Nov 23, 2014
0
0
Neuroscience
Improving babies' language skills before they're even old enough to speak
In the first months of life, when babies begin to distinguish sounds that make up language from all the other sounds in the world, they can be trained to more effectively recognize which sounds "might" be language, accelerating ...
Sep 30, 2014
3
0
Psychology & Psychiatry
Twin study suggests that language delay due more to nature than nurture
A study of 473 sets of twins followed since birth found that compared to single-born children, 47 percent of 24-month-old identical twins had language delay compared to 31 percent of non-identical twins. Overall, twins had ...
Jul 21, 2014
0
0
HIV & AIDS
Protection against HSV-2 is added benefit of tenofovir
(HealthDay)—Tenofovir for HIV-1 preexposure prophylaxis (PrEP) provides the added benefit of protection against herpes simplex virus type 2 (HSV-2) acquisition, according to a study published in the July 1 issue of the ...
Jul 2, 2014
0
0
HIV & AIDS
HIV vaccine research must consider various immune responses
Last year, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, held a scientific meeting to examine why certain investigational HIV vaccines may have increased susceptibility ...
Apr 3, 2014
0
0
Psychology & Psychiatry
Tie between toddlers' shyness, language abilities reflects reticence to respond
Previous research has suggested that shy children have difficulties with language. Now, a new longitudinal study paints a more nuanced picture. The study, of 816 toddlers, found that children who are inhibited in their behavior ...
Feb 3, 2014
0
0
Medications
Bayer launches 1.9-bn-euro bid for Norway's Algeta
German pharmaceuticals giant Bayer said Thursday it has launched a 1.9-billion-euro ($2.6-billion) bid to buy Norwegian cancer treatment specialist Algeta.
Dec 19, 2013
0
0
Medications
US drugs firm Mylan completes $1.75 bln India buyout
US generic drug specialist Mylan said Thursday it had completed its $1.75 billion acquisition of a unit of India's Strides Arcolab, boosting its presence in the high-growth injectable drugs market.
Dec 5, 2013
0
0
